2-190246167-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_014362.4(HIBCH):c.796G>A(p.Asp266Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00425 in 1,581,178 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D266D) has been classified as Likely benign.
Frequency
Consequence
NM_014362.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HIBCH | NM_014362.4 | c.796G>A | p.Asp266Asn | missense_variant | 10/14 | ENST00000359678.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HIBCH | ENST00000359678.10 | c.796G>A | p.Asp266Asn | missense_variant | 10/14 | 1 | NM_014362.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00298 AC: 453AN: 152118Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00253 AC: 632AN: 249884Hom.: 2 AF XY: 0.00249 AC XY: 336AN XY: 135178
GnomAD4 exome AF: 0.00438 AC: 6261AN: 1428942Hom.: 17 Cov.: 26 AF XY: 0.00424 AC XY: 3025AN XY: 713134
GnomAD4 genome ? AF: 0.00298 AC: 453AN: 152236Hom.: 2 Cov.: 32 AF XY: 0.00258 AC XY: 192AN XY: 74416
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 12, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | HIBCH: BP4, BS2 - |
Beta-hydroxyisobutyryl-CoA deacylase deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at